Palmitine
CAS 3486-67-7
Palmitine (CAS 3486-67-7) is a pharmaceutical compound with 5 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 32663.262 nM | 9 | - |
| - | Potency | 13517.185714285713 nM | 7 | - |
| - | AC50 | 12589.25 nM | 1 | - |
| - | Ki | 16900 nM | 1 | - |
| - | MIC | 44700 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Palmitine used for in pharmaceutical contexts?
Palmitine (CAS 3486-67-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Palmitine?
No adverse-event association or SIDER side-effect rows are rendered for Palmitine in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Palmitine also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for PALMATINE with EU status "permitted".
What clinical phase is Palmitine in?
No phase 1-4 clinical development badge is rendered for Palmitine because the matched compound identifier rows do not contain a max-phase value.